LINC00511 and cervical carcinoma: LINC00511 is upregulated in cervical cancers and could promote PLD1 expression by enriching RXRA to the promoter region of PLD1 and activating PLD1 promoter activity, thus enhancing proliferation and inhibiting the autophagy and apoptosis of cervical cancer cells 178.